Quality of life (QoL) by response: An interim analysis of patients (pts) with squamous (SCC) NSCLC treated with nab-paclitaxel/carboplatin (nab-P/C) induction therapy in the phase III ABOUND.sqm study.

TY - JOUR

T1 - Quality of life (QoL) by response: An interim analysis of patients (pts) with squamous (SCC) NSCLC treated with nab-paclitaxel/carboplatin (nab-P/C) induction therapy in the phase III ABOUND.sqm study.

AU - Langer, Corey J.

AU - Hirsh, Vera

AU - Amiri, Katayoun

AU - Ko, Amy

AU - Knoble, Jeanna L.

AU - Johnson, Melissa Lynne

AU - Jotte, Robert M.

AU - McCleod, Michael

AU - Ong, Teng Jin

AU - Page, Ray D.

AU - Spigel, David R.

AU - West, Howard Jack

N1 - 63 Background: The correlation of radiological response and pt-reported outcomes (PROs) in advanced NSCLC remains underreported. This interim analysis evaluated QoL by response (RECIST v1.1) in SCC NSCLC pts treated with nab-P/C during the induction part of the ABOUND.sqm study.

PY - 2016/3/1

Y1 - 2016/3/1

UR - https://ascopubs.org/doi/abs/10.1200/jco.2016.34.7_suppl.63

U2 - 10.1200/JCO.2016.34.7_SUPPL.63

DO - 10.1200/JCO.2016.34.7_SUPPL.63

M3 - Article

VL - 34

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -